This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 May-Aug;21(2-3):139-65.

doi: 10.1081/rrs-100107426.

Quantification of receptor interactions using binding methods

S Lazareno¹

Affiliations

PMID: 11757681
DOI: 10.1081/rrs-100107426

Review

Quantification of receptor interactions using binding methods

S Lazareno. J Recept Signal Transduct Res. 2001 May-Aug.

. 2001 May-Aug;21(2-3):139-65.

doi: 10.1081/rrs-100107426.

Author

S Lazareno¹

Affiliation

¹ MRC Collaborative Centre, London, England.

PMID: 11757681
DOI: 10.1081/rrs-100107426

No abstract available

PubMed Disclaimer

Similar articles

How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
MacKay D. MacKay D. J Pharm Pharmacol. 1978 May;30(5):312-3. doi: 10.1111/j.2042-7158.1978.tb13237.x. J Pharm Pharmacol. 1978. PMID: 26747 No abstract available.
Experimental procedure for estimating the dissociation constant of noncompetitive interactants. Part I.
Orsetti M. Orsetti M. Boll Soc Ital Biol Sper. 1986 Jan 31;62(1):51-7. Boll Soc Ital Biol Sper. 1986. PMID: 3718726 No abstract available.
[Theoretical studies on interactions between pharmacon models and ionic receptor binding sites (author's transl)].
Höltje HD. Höltje HD. Arch Pharm (Weinheim). 1978 Jan;311(1):2-11. doi: 10.1002/ardp.19783110103. Arch Pharm (Weinheim). 1978. PMID: 626563 German. No abstract available.
pA2 and receptor differentiation: a statistical analysis of competitive antagonism.
Tallarida RJ, Cowan A, Adler MW. Tallarida RJ, et al. Life Sci. 1979 Aug 20;25(8):637-54. doi: 10.1016/0024-3205(79)90505-8. Life Sci. 1979. PMID: 388133 Review. No abstract available.
Drugs and endogenous ligands compete for receptor occupancy.
Colburn WA. Colburn WA. J Clin Pharmacol. 1994 Dec;34(12):1148-52. doi: 10.1002/j.1552-4604.1994.tb04724.x. J Clin Pharmacol. 1994. PMID: 7738208 Review.

See all similar articles

Cited by

Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use.
Shaw RC, Tamagnan GD, Tavares AAS. Shaw RC, et al. Front Neurosci. 2020 Oct 1;14:871. doi: 10.3389/fnins.2020.00871. eCollection 2020. Front Neurosci. 2020. PMID: 33117115 Free PMC article. Review.
A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands.
Wojciechowski MN, Schreiber S, Jose J. Wojciechowski MN, et al. Pharmaceuticals (Basel). 2023 May 7;16(5):710. doi: 10.3390/ph16050710. Pharmaceuticals (Basel). 2023. PMID: 37242492 Free PMC article.
A FRET-Based Assay for the Identification of PCNA Inhibitors.
Hardebeck S, Schreiber S, Adick A, Langer K, Jose J. Hardebeck S, et al. Int J Mol Sci. 2023 Jul 24;24(14):11858. doi: 10.3390/ijms241411858. Int J Mol Sci. 2023. PMID: 37511614 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information